Suzuken (9987) Stock Overview

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy, and Healthcare-Related Services. The Pharmaceutical Distribution Business segment is involved in the purchase and sale of ethical drugs, pharmaceuticals, diagnostic reagents, and medical equipment and supplies to medical institutions and insurance pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals, and diagnostic reagents focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment is involved in the medication instruction and drug management for in-home patients, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment delivers drugs; provides nursing care services; manufactures, sells, and leases nursing care and medical equipment, such as electrocardiographs, blood pressure monitors, and stethoscopes under Kenz brand name; distributes orphan drugs; develops and operates a product control system for medical materials; sells food products and fixtures and fittings; and develops, manages, and maintains healthcare platforms. This segment also engages in publication and PR activities in the field of medical care and health; and insurance agency business, as well as provides remote image diagnostic support services. In addition, it engages in pharmaceutical logistics business. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.